Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance its ...

In the past, Dr. Horowitz had been a paid consultant for Purple Biotech.

Rethinking sourcing strategies can mitigate operational risks posed by growing ideological differences. The global political ...

This 1620 version of The Yellow Emperor’s Classic of Internal Medicine, first compiled some 2,100 years ago, includes a map of qi lines ... since emigrating from Taiwan, he still speaks English ...

Vor Biopharma has a 1 year low of $0.63 and a 1 year high of $2.43. The stock has a market capitalization of $95.46 million, a PE ratio of -0.84 and a beta of -0.51.

TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company ...

This acquisition merges Tanvex's expertise in biosimilar development and commercialization at its FDA-licensed commercial-scale facility in San Diego with Bora's extensive global early-stage biologics ...

Tanvex BioPharma, Inc. ("Tanvex"), a contract development ... Bora's extensive global early-stage biologics CDMO capabilities in Taiwan, leveraging a proven track record of over 100 successful ...

RedHill Biopharma (RDHL) announced the initiation of a Phase 2 clinical study to evaluate the efficacy of its opaganib candidate in combination with darolutamide in men with metastatic castrate ...

LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a ...

In 2025, Taiwan's total export value reached US$475.07 billion—its second-best performance since 2022. Over the past two ...